oPatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

Cardiomyopathies are defined as myocardial disorders in which the heart muscle is structurally and functionally abnormal, in the absence of coronary artery disease, hypertension, valvular disease and congenital heart disease sufficient to cause the observed myocardial abnormality.[1] The degree of cardiac dysfunction ranges from lifelong symptomless forms to major health problems, such as progressive heart failure, arrhythmia, thromboembolism and sudden cardiac death.[2]

Save time & improve your PDP on

  • Notes Add notes to any clinical page and create a reflective diary
  • Track Automatically track and log every page you have viewed
  • Print Print and export a summary to use in your appraisal
Click to find out more »

The four major types of cardiomyopathy are (see links for separate articles):[6]

  • Dilated cardiomyopathy: the most common form; the left or both ventricles are dilated with impaired contraction. Causes include: ischaemic, alcoholic, toxic, thyroid disorders, valvular, familial/genetic and idiopathic.
  • Hypertrophic cardiomyopathy: the second most common; estimated adult prevalence is 1:500, with left and/or right ventricular hypertrophy. Usually familial (autosomal dominant).
  • Restrictive cardiomyopathy: rare; estimated prevalence between 1:1,000 and 1:5,000, with restrictive filling and reduced diastolic filling of one/both ventricles and normal or near-normal systolic function. Causes include: amyloidosis, endomyocardial fibrosis, and idiopathic.
  • Arrhythmogenic right ventricular cardiomyopathy: with fibro-fatty replacement of right ventricular myocardium, Uhl's anomaly (parchment heart). The cause is unknown; the familial form is usually autosomal dominant with incomplete penetrance but may be recessive, eg Naxos disease (autosomal recessive family from the Greek Island).

Classifications have also included an unclassified group consisting of causes with no typical features of the above, eg endocardial fibroelastosis, non-compacted myocardium, systolic dysfunction with minimal dilatation, mitochondrial diseases.[7]

  • In contrast to coronary heart disease having a higher incidence in the elderly, cardiomyopathies can occur at younger ages. Therefore, cardiomyopathy should be suspected in any young person presenting with a heart failure, arrhythmias or thromboembolism.[2]
  • Clinically overt hypertrophic cardiomyopathy is the most common cause of sudden unexpected death in childhood.[8]
  • Restrictive cardiomyopathy is rare in childhood and has a poor outcome once symptoms develop.[9]
  • A familial cause has been shown in 50% of patients with hypertrophic cardiomyopathy, 35% with dilated, and 30% with arrhythmogenic right ventricular cardiomyopathy. Restrictive cardiomyopathy is usually not familial.
  • Blood tests: FBC, ESR, renal function tests, electrolytes, LFTs, cardiac enzymes and TFTs.
  • CXR.
  • ECG: a normal ECG is uncommon in any form of cardiomyopathy.
  • Transthoracic Doppler echocardiography: this can confirm the diagnosis of hypertrophic cardiomyopathy, help to distinguish between restrictive cardiomyopathy and constrictive pericarditis, exclude valvular heart disease, and assess the severity of ventricular dysfunction in dilated cardiomyopathies.
  • Brain natriuretic peptide (BNP) has a potential role as a test for ventricular dysfunction.
  • Non-invasive stress testing is recommended only for patients who have a high probability of underlying ischaemic heart disease, prior myocardial infarction, or extensive hibernating myocardium or for evaluation for possible heart transplantation.
  • Cardiac catheterisation can help in excluding coronary artery disease as the cause of the dilated cardiomyopathy and in distinguishing restrictive cardiomyopathy from constrictive pericarditis.
  • Magnetic resonance imaging: this may help to distinguish between constrictive disease and restrictive cardiomyopathy.
  • Right ventricular endomyocardial biopsy is occasionally used to distinguish between myocarditis and idiopathic dilated cardiomyopathy. A normal result does not rule out cardiomyopathy.
  • Treatment options are symptomatic and mainly directed towards treatment of heart failure and prevention of thromboembolism and sudden death.
  • Identification of patients with high risk for major arrhythmic events is important because implantable cardioverter defibrillators can prevent sudden death.
  • All patients with cardiomyopathy require a thorough cardiological assessment of functional capacity, cardiac function and risk of serious arrhythmia.
  • Patients with hypertrophic obstructive cardiomyopathy (HOCM) may be treated by surgical or non-surgical myectomy. Non-surgical reduction involves injecting alcohol into the heart via a catheter inserted into the femoral artery. This destroys part of the muscle in the septum, which then becomes thinner.[10]
  • Heart transplant may be required.

Further reading & references

  1. Kaski JP, Elliott P; The classification concept of the ESC Working Group on myocardial and pericardial Herz. 2007 Sep;32(6):446-51.
  2. Franz WM, Muller OJ, Katus HA; Cardiomyopathies: from genetics to the prospect of treatment. Lancet. 2001 Nov 10;358(9293):1627-37.
  3. Huffman C, Wagman G, Fudim M, et al; Reversible cardiomyopathies--a review. Transplant Proc. 2010 Nov;42(9):3673-8.
  4. Townsend D, Yasuda S, Metzger J; Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach. Expert Rev Cardiovasc Ther. 2007 Jan;5(1):99-109.
  5. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al; Current state of knowledge on aetiology, diagnosis, management, and therapy of Eur J Heart Fail. 2010 Aug;12(8):767-78.
  6. Wexler RK, Elton T, Pleister A, et al; Cardiomyopathy: an overview. Am Fam Physician. 2009 May 1;79(9):778-84.
  7. Sanchez Torres RJ, Calderon R; The cardiomyopathies, a review for the primary physician. P R Health Sci J. 2004 Dec;23(4):285-92.
  8. Ostman-Smith I; Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent Fundam Clin Pharmacol. 2010 Oct;24(5):637-52. doi:
  9. Denfield SW, Webber SA; Restrictive cardiomyopathy in childhood. Heart Fail Clin. 2010 Oct;6(4):445-52, viii.
  10. Non-surgical reduction of myocardial septum, NICE (2004)

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Colin Tidy
Current Version:
Peer Reviewer:
Dr Hayley Willacy
Last Checked:
Document ID:
1913 (v23)